GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $316,000 | +1.6% | 7,265 | +1.9% | 0.02% | +9.1% |
| Q1 2022 | $311,000 | -1.3% | 7,132 | -0.1% | 0.02% | -4.3% |
| Q4 2021 | $315,000 | +4.3% | 7,138 | -9.6% | 0.02% | 0.0% |
| Q3 2021 | $302,000 | +14.0% | 7,894 | +18.8% | 0.02% | +9.5% |
| Q2 2021 | $265,000 | +26.2% | 6,645 | +13.1% | 0.02% | +10.5% |
| Q1 2021 | $210,000 | -26.1% | 5,874 | -24.0% | 0.02% | -29.6% |
| Q4 2020 | $284,000 | +7.2% | 7,731 | +9.6% | 0.03% | -10.0% |
| Q3 2020 | $265,000 | -6.0% | 7,053 | +2.0% | 0.03% | -21.1% |
| Q2 2020 | $282,000 | +16.0% | 6,917 | +7.9% | 0.04% | -13.6% |
| Q1 2020 | $243,000 | -20.1% | 6,413 | -0.8% | 0.04% | +7.3% |
| Q4 2019 | $304,000 | +9.0% | 6,467 | -1.1% | 0.04% | -4.7% |
| Q3 2019 | $279,000 | -4.5% | 6,538 | -10.3% | 0.04% | -8.5% |
| Q2 2019 | $292,000 | -29.0% | 7,290 | -25.8% | 0.05% | -39.7% |
| Q1 2019 | $411,000 | +33.4% | 9,826 | +22.4% | 0.08% | +20.0% |
| Q4 2018 | $308,000 | -1.3% | 8,026 | +3.3% | 0.06% | 0.0% |
| Q3 2018 | $312,000 | -2.2% | 7,770 | -1.8% | 0.06% | -9.7% |
| Q2 2018 | $319,000 | +21.3% | 7,912 | +17.7% | 0.07% | +7.5% |
| Q1 2018 | $263,000 | -93.2% | 6,721 | -92.9% | 0.07% | -95.6% |
| Q3 2017 | $3,868,000 | -4.5% | 95,282 | +1.5% | 1.53% | -2.4% |
| Q2 2017 | $4,050,000 | +0.8% | 93,920 | -1.4% | 1.57% | +0.1% |
| Q1 2017 | $4,017,000 | +1553.1% | 95,292 | +1411.4% | 1.57% | +1514.4% |
| Q4 2016 | $243,000 | -94.0% | 6,305 | -93.3% | 0.10% | -93.7% |
| Q3 2016 | $4,081,000 | +1.8% | 94,624 | +2.3% | 1.54% | -4.9% |
| Q2 2016 | $4,008,000 | +14.9% | 92,480 | +7.5% | 1.62% | +9.7% |
| Q1 2016 | $3,489,000 | +1.6% | 86,044 | +1.1% | 1.48% | +4.3% |
| Q4 2015 | $3,435,000 | -3.0% | 85,130 | -7.6% | 1.42% | -20.5% |
| Q3 2015 | $3,542,000 | +37.2% | 92,127 | +64.0% | 1.79% | +27.3% |
| Q3 2014 | $2,582,000 | -3.5% | 56,162 | +12.2% | 1.40% | -12.7% |
| Q2 2014 | $2,677,000 | +56.1% | 50,049 | +55.9% | 1.61% | +37.4% |
| Q1 2014 | $1,715,000 | +8.3% | 32,107 | +8.3% | 1.17% | -0.2% |
| Q4 2013 | $1,583,000 | – | 29,646 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |